Live feed11:52:00·197dPRReleasevia QuantisnowArrowhead Pharmaceuticals Announces FDA Approval of REDEMPLO® (plozasiran) to Reduce Triglycerides in Adults with Familial Chylomicronemia Syndrome (FCS)ByQuantisnow·Wall Street's wire, on your screen.ARWR· Arrowhead Pharmaceuticals Inc.Health Care
